Using hemoglobin A1C as a predicting model for time interval from pre-diabetes progressing to diabetes

Area of Science:

• Endocrinology
• Metabolic Diseases
• Biostatistics

Background:

• Early identification of individuals at high risk for diabetes is crucial for timely intervention.
• Random plasma glucose measurements are often more effective than fasting glucose for early diabetes detection.
• Hemoglobin A1c (HbA1c) is a valuable diagnostic tool for monitoring glycemic control and predicting diabetes progression.

Purpose of the Study:

• To evaluate the time interval between pre-diabetes and diabetes using HbA1c as a diagnostic marker.
• To develop and validate a mathematical model for predicting diabetes progression.
• To assess the utility of HbA1c in identifying individuals at high risk for diabetes.

Main Methods:

• Utilized the Taipei Medical University Affiliated Hospital Patient Profile Database (AHPPD) from January 2007 to June 2011.
• Selected patients who progressed to requiring anti-diabetic drugs.
• Employed a mathematical model to predict the time interval for HbA1c values ranging from 5.7% to 6.5%.

Main Results:

• The overall predicted time interval for participants with HbA1c between 5.7% and 6.5% was 907 days (approximately 2.49 years).
• Time intervals varied by risk group: 1169.3 days (low risk), 1080.5 days (increased risk), and 729.4 days (diabetes group).
• The model indicated an average of 2.49 years for patients to reach an HbA1c of 6.5%.

Conclusions:

• The developed prediction model effectively aids in early diabetes diagnosis and risk stratification.
• HbA1c levels prior to anti-diabetic drug initiation can predict pre-diabetes to diabetes progression within 2.49 years, independent of age and gender.
• Further research is recommended to validate this model for long-term diabetes prediction.